规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Desonide is a nonfluorinated corticosteroid anti-inflammatory agent used topically for dermatoses[3]. Desonide topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions (eg, atopic dermatitis). Desonide showed depigmenting properties in women with axillary hyperpigmentation. It induced significant colorimetric improvement compared with placebo.[4]. The in vitro skin permeation showed that desonide reached the site of action of the topical corticosteroids, from both formulations (57.8 and 51.7 µg/cm2); however, the desonide amount retained in the dermis was lower with D-GC (gel-cream developed)[5]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01935310 | Photoaging | Not Applicable | Completed | - | Colombia ... 展开 >> Centro de servicios CES Sabaneta Medellín, Antioquia, Colombia, 050021 收起 << |
NCT03758365 | Vasoconstriction | Phase 1 | Recruiting | January 15, 2019 | France ... 展开 >> CPCAD Recruiting Nice, France, 06200 Contact: Catherine Queille-Roussel, MD 收起 << |
NCT02732314 | Dermatitis, Atopic ... 展开 >> Eczema 收起 << | Phase 4 | Completed | - | United States, North Carolina ... 展开 >> Wake Research Associates, LLC Raleigh, North Carolina, United States, 27612 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.40mL 0.48mL 0.24mL |
12.00mL 2.40mL 1.20mL |
24.01mL 4.80mL 2.40mL |
CAS号 | 638-94-8 |
分子式 | C24H32O6 |
分子量 | 416.51 |
SMILES Code | O=C(C=C1CC[C@@]([H])([C@@]2(C[C@@]3([C@]4(OC(C)(O3)C)C(CO)=O)[H])[H])[C@@]5([C@H](C[C@@]24C)O)[H])C=C[C@@]15C |
MDL No. | MFCD00866151 |
别名 | 地奈德 ;Budesonide acetonide |
运输 | 蓝冰 |
InChI Key | WBGKWQHBNHJJPZ-LECWWXJVSA-N |
Pubchem ID | 5311066 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
DMSO: 105 mg/mL(252.1 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |
2% DMSO+49% PEG 300+dd water 10 mg/mL |